{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:04:11Z","timestamp":1761919451276},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00277-011-1195-2","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T01:08:21Z","timestamp":1299546501000},"page":"1255-1264","source":"Crossref","is-referenced-by-count":16,"title":["Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia"],"prefix":"10.1007","volume":"90","author":[{"given":"Jungwon","family":"Huh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Geun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeo Kyeoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeoung","family":"Joon Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang Soo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Kyung","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goong Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hwan Dennis","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"key":"1195_CR1","first-page":"32","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL et al (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 32\u201337","edition":"4"},{"issue":"2","key":"1195_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2002","unstructured":"Johansson B, Fioretos T, Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107(2):76\u201394","journal-title":"Acta Haematol"},{"key":"1195_CR3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2008-02-130435","volume":"112","author":"JP Maciejewski","year":"2008","unstructured":"Maciejewski JP, Mufti GJ (2008) Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood 112:965\u2013974","journal-title":"Blood"},{"key":"1195_CR4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2009.07757.x","volume":"146","author":"JP Maciejewski","year":"2009","unstructured":"Maciejewski JP, Tiu RV, O'Keefe C (2009) Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies. Br J Haematol 146:479\u2013488","journal-title":"Br J Haematol"},{"issue":"2","key":"1195_CR5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2004.00356.x","volume":"74","author":"Y Yoong","year":"2005","unstructured":"Yoong Y, VanDeWalker TJ, Carlson RO, Dewald GW, Tefferi A (2005) Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia. Eur J Haematol 74(2):124\u2013127","journal-title":"Eur J Haematol"},{"issue":"4","key":"1195_CR6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/cncr.23607","volume":"113","author":"DH Kim","year":"2008","unstructured":"Kim DH, Popradi G, Sriharsha L, Kamel-Reid S, Chang H, Messner HA, Lipton JH (2008) No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR\/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia. Cancer 113(4):772\u2013781","journal-title":"Cancer"},{"issue":"6","key":"1195_CR7","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood-2004-06-2208","volume":"105","author":"A Quintas-Cardama","year":"2005","unstructured":"Quintas-Cardama A, Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Verstovsek S, Rios MB, Hayes K, Glassman A, Bekele BN, Zhou X, Cortes J (2005) Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood 105(6):2281\u20132286","journal-title":"Blood"},{"key":"1195_CR8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/10428190902980889","volume":"50","author":"LA Godley","year":"2009","unstructured":"Godley LA (2009) Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues. Leuk Lymphoma 50:871\u2013872","journal-title":"Leuk Lymphoma"},{"key":"1195_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCO.0b013e328011a8c1","volume":"19","author":"A Dutt","year":"2007","unstructured":"Dutt A, Beroukhim R (2007) Single nucleotide polymorphism array analysis of cancer. Curr Opin Oncol 19:43\u201349","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"1195_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/138920207781386924","volume":"8","author":"X Mao","year":"2007","unstructured":"Mao X, Young BD, Lu YJ (2007) The application of single nucleotide polymorphism microarrays in cancer research. Curr Genomics 8(4):219\u2013228","journal-title":"Curr Genomics"},{"issue":"3","key":"1195_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molmed.2009.01.005","volume":"15","author":"M Tuna","year":"2009","unstructured":"Tuna M, Knuutila S, Mills GB (2009) Uniparental disomy in cancer. Trends Mol Med 15(3):120\u2013128","journal-title":"Trends Mol Med"},{"issue":"17","key":"1195_CR12","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352(17):1779\u20131790","journal-title":"N Engl J Med"},{"issue":"31","key":"1195_CR13","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1200\/JCO.2009.21.9840","volume":"27","author":"RV Tiu","year":"2009","unstructured":"Tiu RV, Gondek LP, O'Keefe CL, Huh J, Sekeres MA, Elson P, McDevitt MA, Wang XF, Levis MJ, Karp JE, Advani AS, Maciejewski JP (2009) New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia. J Clin Oncol 27(31):5219\u20135226","journal-title":"J Clin Oncol"},{"key":"1195_CR14","unstructured":"ISCN 2009: an international system for human cytogenetic nomenclature (2009). In: Shaffer LG and Tommerup N., Editors, S. Karger, Basel."},{"key":"1195_CR15","first-page":"186","volume":"8","author":"NC Cross","year":"1994","unstructured":"Cross NC, Melo JV, Feng L, Goldman JM (1994) An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 8:186\u2013189","journal-title":"Leukemia"},{"issue":"7","key":"1195_CR16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.leu.2402969","volume":"17","author":"E Kolomietz","year":"2003","unstructured":"Kolomietz E, Marrano P, Yee K, Thai B, Braude I, Kolomietz A, Chun K, Minkin S, Kamel-Reid S, Minden M, Squire JA (2003) Quantitative PCR identifies a minimal deleted region of 120\u00a0kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome. Leukemia 17(7):1313\u20131323","journal-title":"Leukemia"},{"key":"1195_CR17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/meth.2001.1266","volume":"25","author":"MS Rajeevan","year":"2001","unstructured":"Rajeevan MS, Ranamukhaarachchi DG, Vernon SD, Unger ER (2001) Use of real time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25:443\u2013451","journal-title":"Methods"},{"key":"1195_CR18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","volume":"349","author":"TP Hughes","year":"2003","unstructured":"Hughes TP, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley ML, Gathmann I, Bolton AE, van Hoomissen IC, Goldman JM, Radich JP, International Randomised Study of Interferon versus STI571 (IRIS) Study Group (2003) Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med 349:1423\u20131432","journal-title":"N Engl J Med"},{"issue":"7","key":"1195_CR19","first-page":"2167","volume":"8","author":"HM Kantarjian","year":"2002","unstructured":"Kantarjian HM, O'Brien S, Cortes JE, Smith TL, Rios MB, Shan J, Yang Y, Giles FJ, Thomas DA, Faderl S, Garcia-Manero G, Jeha S, Wierda W, Issa JP, Kornblau SM, Keating M, Resta D, Capdeville R, Talpaz M (2002) Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib\u00a0mesylate. Clin Cancer Res 8(7):2167\u20132176","journal-title":"Clin Cancer Res"},{"key":"1195_CR20","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2008-04-150680","volume":"112","author":"S Branford","year":"2008","unstructured":"Branford S, Fletcher L, Cross NC, M\u00fcller MC, Hochhaus A, Kim DW, Radich JP, Saglio G, Pane F, Kamel-Reid S, Wang YL, Press RD, Lynch K, Rudzki Z, Goldman JM, Hughes T (2008) Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood 112:3330\u20133338","journal-title":"Blood"},{"key":"1195_CR21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3324\/haematol.11172","volume":"92","author":"MC M\u00fcller","year":"2007","unstructured":"M\u00fcller MC, Saglio G, Lin F, Pfeifer H, Press RD, Tubbs RR, Paschka P, Gottardi E, O'Brien SG, Ottmann OG, Stockinger H, Wieczorek L, Merx K, K\u00f6nig H, Schwindel U, Hehlmann R, Hochhaus A (2007) An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. Haematologica 92:970\u2013973","journal-title":"Haematologica"},{"issue":"11","key":"1195_CR22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/gcc.20487","volume":"46","author":"D Brazma","year":"2007","unstructured":"Brazma D, Grace C, Howard J, Melo JV, Holyoke T, Apperley JF, Nacheva EP (2007) Genomic profile of chronic myelogenous leukemia: imbalances associated with disease progression. Genes Chromosom Cancer 46(11):1039\u20131050","journal-title":"Genes Chromosom Cancer"},{"key":"1195_CR23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2009-03-210377","volume":"115","author":"D Nowak","year":"2010","unstructured":"Nowak D, Ogawa S, M\u00fcschen M, Kato M, Kawamata N, Meixel A, Nowak V, Kim HS, Kang S, Paquette R, Chang MS, Thoennissen NH, Mossner M, Hofmann WK, Kohlmann A, Weiss T, Haferlach T, Haferlach C, Koeffler HP (2010) SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. Blood 115:1049\u20131053","journal-title":"Blood"},{"key":"1195_CR24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2010.65","volume":"24","author":"J Boultwood","year":"2010","unstructured":"Boultwood J, Perry J, Zaman R, Fernandez-Santamaria C, Littlewood T, Kusec R, Pellagatti A, Wang L, Clark RE, Wainscoat JS (2010) High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. Leukemia 24:1139\u20131145","journal-title":"Leukemia"},{"issue":"2","key":"1195_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2006.06.006","volume":"170","author":"N Douet-Guilbert","year":"2006","unstructured":"Douet-Guilbert N, Morel F, Quemener S, Maguer A, Le Bris MJ, Morice P, Berthou C, De Braekeleer M (2006) Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia. Cancer Genet Cytogenet 170(2):89\u201392","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"1195_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/gcc.10116","volume":"35","author":"CT Storlazzi","year":"2002","unstructured":"Storlazzi CT, Specchia G, Anelli L, Albano F, Pastore D, Zagaria A, Rocchi M, Liso V (2002) Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients. Genes Chromosom Cancer 35(3):271\u2013276","journal-title":"Genes Chromosom Cancer"},{"issue":"7","key":"1195_CR27","first-page":"952","volume":"91","author":"N Fourouclas","year":"2006","unstructured":"Fourouclas N, Campbell PJ, Bench AJ, Swanton S, Baxter EJ, Huntly BJ, Green AR (2006) Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia. Haematologica 91(7):952\u2013955","journal-title":"Haematologica"},{"key":"1195_CR28","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/carcin\/bgi223","volume":"26","author":"SR Payne","year":"2005","unstructured":"Payne SR, Kemp CJ (2005) Tumor suppressor genetics. Carcinogenesis 26:2031\u20132045","journal-title":"Carcinogenesis"},{"key":"1195_CR29","unstructured":"Huret JP, Genetics DIM. Atlas of Genetics and Cytogenetics in Oncology and Haematology. Available at: http:\/\/atlasgeneticsoncology.org\/index.html ."},{"key":"1195_CR30","unstructured":"http:\/\/www.ncbi.nlm.nih.gov\/gene"},{"issue":"1","key":"1195_CR31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.leu.2403162","volume":"18","author":"AG Reid","year":"2004","unstructured":"Reid AG, Nacheva EP (2004) A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. Leukemia 18(1):178\u2013180","journal-title":"Leukemia"},{"issue":"11","key":"1195_CR32","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1371\/journal.pone.0001225","volume":"2","author":"LP Gondek","year":"2007","unstructured":"Gondek LP, Dunbar AJ, Szpurka H, McDevitt MA, Maciejewski JP (2007) SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS\/MPD-U and MPD. PLoS ONE 2(11):e1225","journal-title":"PLoS ONE"},{"issue":"20","key":"1195_CR33","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-05-2017","volume":"65","author":"J Fitzgibbon","year":"2005","unstructured":"Fitzgibbon J, Smith LL, Raghavan M, Smith ML, Debernardi S, Skoulakis S, Lillington D, Lister TA, Young BD (2005) Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res 65(20):9152\u20139154","journal-title":"Cancer Res"},{"issue":"3","key":"1195_CR34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2008-01-132431","volume":"112","author":"M Raghavan","year":"2008","unstructured":"Raghavan M, Smith LL, Lillington DM, Chaplin T, Kakkas I, Molloy G, Chelala C, Cazier JB, Cavenagh JD, Fitzgibbon J, Lister TA, Young BD (2008) Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia. Blood 112(3):814\u2013821","journal-title":"Blood"},{"issue":"9","key":"1195_CR35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/gcc.20573","volume":"47","author":"M Gupta","year":"2008","unstructured":"Gupta M, Raghavan M, Gale RE, Chelala C, Allen C, Molloy G, Chaplin T, Linch DC, Cazier JB, Young BD (2008) Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. Genes Chromosom Cancer 47(9):729\u2013739","journal-title":"Genes Chromosom Cancer"},{"issue":"9","key":"1195_CR36","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2007-03-079673","volume":"110","author":"A Mohamedali","year":"2007","unstructured":"Mohamedali A, G\u00e4ken J, Twine NA, Ingram W, Westwood N, Lea NC, Hayden J, Donaldson N, Aul C, Gattermann N, Giagounidis A, Germing U, List AF, Mufti GJ (2007) Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood 110(9):3365\u20133373","journal-title":"Blood"},{"issue":"5","key":"1195_CR37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.leu.2404993","volume":"22","author":"K Hussein","year":"2008","unstructured":"Hussein K, Bock O, Theophile K, Seegers A, Arps H, Basten O, Grips KH, Franz-Werner J, B\u00fcsche G, Kreipe H (2008) Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation. Leukemia 22(5):1059\u20131062","journal-title":"Leukemia"},{"issue":"16","key":"1195_CR38","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1200\/JCO.2009.26.7963","volume":"28","author":"F Castagnetti","year":"2010","unstructured":"Castagnetti F, Testoni N, Luatti S, Marzocchi G, Mancini M, Kerim S, Giugliano E, Albano F, Cuneo A, Abruzzese E, Martino B, Palandri F, Amabile M, Iacobucci I, Alimena G, Pane F, Martinelli G, Saglio G, Baccarani M, Rosti G (2010) Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis. J Clin Oncol 28(16):2748\u20132754","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1195-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1195-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1195-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:50:18Z","timestamp":1559022618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1195-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1195"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1195-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,8]]}}}